122 related articles for article (PubMed ID: 2478350)
1. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Robinsky B; Sass R; Fisher B
Dis Colon Rectum; 1989 Nov; 32(11):944-9. PubMed ID: 2478350
[TBL] [Abstract][Full Text] [Related]
2. Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Sass R; Palekar A; Fisher B; Wolmark N
Cancer; 1989 Dec; 64(11):2354-60. PubMed ID: 2804927
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of Jass classification of rectal cancer compared to original Dukes system].
Szynglarewicz B; Grzebieniak Z; Forgacz J; Pudełko M; Rapała M
Wiad Lek; 2005; 58(9-10):491-4. PubMed ID: 16529057
[TBL] [Abstract][Full Text] [Related]
4. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
6. Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.
Mander BJ; Carney LJ; Scott HJ; Donaldson DR
Surgeon; 2006 Aug; 4(4):227-30. PubMed ID: 16892840
[TBL] [Abstract][Full Text] [Related]
7. A Dukes/Jass combination--is it more discriminating?
Haslam AC; Pearson JM; Bisset DL; Michie HR; Hobbiss JH
Colorectal Dis; 2006 Jun; 8(5):418-22. PubMed ID: 16684086
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of eosinophils and mast cells in rectal cancer: findings from the National Surgical Adjuvant Breast and Bowel Project (protocol R-01).
Fisher ER; Paik SM; Rockette H; Jones J; Caplan R; Fisher B
Hum Pathol; 1989 Feb; 20(2):159-63. PubMed ID: 2562788
[TBL] [Abstract][Full Text] [Related]
9. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
10. Value of assessment of ploidy in rectal cancers.
Fisher ER; Siderits RH; Sass R; Fisher B
Arch Pathol Lab Med; 1989 May; 113(5):525-8. PubMed ID: 2712675
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma.
Meguerditchian AN; Bairati I; Lagacé R; Harel F; Kibrité A
Am J Surg; 2005 Jun; 189(6):707-13. PubMed ID: 15910724
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic value of Jass' histopathological classification of cancer of the left colon and rectum].
Secco GB; Fardelli R; Lapertosa G; Fulcheri E; Rovida S; Ratto GB; Prior C
Minerva Chir; 1990 Nov; 45(21-22):1347-53. PubMed ID: 2097559
[TBL] [Abstract][Full Text] [Related]
13. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma.
Michelassi F; Block GE; Vannucci L; Montag A; Chappell R
Ann Surg; 1988 Sep; 208(3):379-89. PubMed ID: 3421761
[TBL] [Abstract][Full Text] [Related]
14. Large bowel cancer: surgical pathology and its relationship to survival.
Phillips RK; Hittinger R; Blesovsky L; Fry JS; Fielding LP
Br J Surg; 1984 Aug; 71(8):604-10. PubMed ID: 6743980
[TBL] [Abstract][Full Text] [Related]
15. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.
Ilyas M; Novelli M; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Talbot IC
J Clin Pathol; 1997 Mar; 50(3):218-22. PubMed ID: 9155672
[TBL] [Abstract][Full Text] [Related]
16. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer.
Neoptolemos JP; Oates GD; Newbold KM; Robson AM; McConkey C; Powell J
Br J Surg; 1995 Feb; 82(2):184-7. PubMed ID: 7749683
[TBL] [Abstract][Full Text] [Related]
17. Prognostic staging of extraperitoneal rectal cancer.
Henrichsen S; Christiansen J
Dis Colon Rectum; 1989 Mar; 32(3):214-8. PubMed ID: 2920628
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04).
Mamounas E; Wieand S; Wolmark N; Bear HD; Atkins JN; Song K; Jones J; Rockette H
J Clin Oncol; 1999 May; 17(5):1349-55. PubMed ID: 10334518
[TBL] [Abstract][Full Text] [Related]
19. New grade-related prognostic variable for rectal cancer.
Gagliardi G; Stepniewska KA; Hershman MJ; Hawley PR; Talbot IC
Br J Surg; 1995 May; 82(5):599-602. PubMed ID: 7613924
[TBL] [Abstract][Full Text] [Related]
20. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
